相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nucleic acid quantity and quality from paraffin blocks: Defining optimal fixation, processing and DNA/RNA extraction techniques
Gulisa Turashvili et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
DNA identification of formalin-fixed organs is affected by fixation time and type of fixatives: using the AmpFlSTR® Identifiler® PCR Amplification Kit
Mami Taguchi et al.
MEDICINE SCIENCE AND THE LAW (2012)
KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
N. Knijn et al.
BRITISH JOURNAL OF CANCER (2011)
Heterogeneity of KRAS Status May Explain the Subset of Discordant KRAS Status Between Primary and Metastatic Colorectal Cancer
Toshiaki Watanabe et al.
DISEASES OF THE COLON & RECTUM (2011)
Biased Discordance of KRAS Mutation Detection in Archived Colorectal Cancer Specimens Between the ARMS-Scorpion Method and Direct Sequencing
Hideaki Bando et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme
Elisabeth Dequeker et al.
VIRCHOWS ARCHIV (2011)
Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
Stephan E. Baldus et al.
CLINICAL CANCER RESEARCH (2010)
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Jean-Yves Douillard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Usefulness of Peptide Nucleic Acid (PNA)-Clamp Smart Amplification Process Version 2 (SmartAmp2) for Clinical Diagnosis of KRAS Codon 12 Mutations in Lung Adenocarcinoma Comparison of PNA-Clamp SmartAmp2 and PCR-Related Methods
Takuya Araki et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
Astrid Lievre et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Rapid Screening Assay for KRAS Mutations by the Modified Smart Amplification Process
Kenji Tatsumi et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
Daniele Santini et al.
ONCOLOGIST (2008)
Rapid detection of epidermal growth factor receptor mutations in lung cancer by the SMart-Amplification process
Kanako Hoshi et al.
CLINICAL CANCER RESEARCH (2007)
Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue:: A BrainNet Europe study
Isidre Ferrer et al.
BRAIN PATHOLOGY (2007)
Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology
Yasumasa Mitani et al.
NATURE METHODS (2007)
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
W Pao et al.
PLOS MEDICINE (2005)
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations
I Albanese et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Intratumoral heterogeneity of genetic changes in primary colorectal carcinomas with metastasis
H Fukunari et al.
SURGERY TODAY (2003)
分享论文
